The site you are about to enter is intended for US healthcare professionals.
Are you a US healthcare professional?
Confirm and enter Visit patient siteAttend a nearby educational event about AMVUTTRA® (vutrisiran)
Upcoming events
Patient Educational Event
King of Prussia, Pennsylvania
April 21, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Sue, joined by Patient Ambassador, John, treated with AMVUTTRA..
Register
Patient Educational Event
Silverdale, Washington
April 23, 2026 |
6:00 PM-7:30 PM PT
Hear from an Alnylam Patient Education Liaison, Stacey, joined by Patient Ambassador, Tim, treated with AMVUTTRA.
Register
Patient Educational Event
Cincinnati, Ohio
April 23, 2026 |
6:30 PM-8:00 PM ET
Hear from an Alnylam Patient Education Liaison, Shane, joined by Patient Ambassador, Kelly, treated with AMVUTTRA, and Elizabeth Hushka, a healthcare professional.
Register
Patient Educational Event
San Diego, California
April 24, 2026 |
12:00 PM-1:30 PM PT
Hear from an Alnylam Patient Education Liaison, Rita, joined by Patient Ambassador, Steve, treated with AMVUTTRA, and Jennifer Keeley, a healthcare professional.
Register
Patient Educational Event
Bismarck, North Dakota
April 25, 2026 |
3:00 PM-4:30 PM MT
Hear from an Alnylam Patient Education Liaison, Jason, joined by Patient Ambassador, Cece, treated with AMVUTTRA, and Nayan Desai, a healthcare professional.
Register
Patient Educational Event
Tacoma, Washington
April 25, 2026 |
5:30 PM-7:00 PM PT
Hear from an Alnylam Patient Education Liaison, Stacey.
Register
Patient Educational Event
Bismarck, North Dakota
April 26, 2026 |
3:00 PM-4:30 PM MT
Hear from an Alnylam Patient Education Liaison, Jason, joined by Patient Ambassador, Cece, treated with AMVUTTRA, and Nayan Desai, a healthcare professional.
Register
Patient Educational Event
Hackensack, New Jersey
April 28, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Christopher, joined by Patient Ambassador, Tim, treated with AMVUTTRA, and Olakunle Akinboboye, a healthcare professional.
Register
Patient Educational Event
Huntingdon Valley, Pennsylvania
April 29, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Sue, joined by Patient Ambassador, Marc, treated with AMVUTTRA.
Register
Patient Educational Event
Fayetteville, Georgia
April 30, 2026 |
6:00 PM-8:00 PM ET
Hear from an Alnylam Patient Education Liaison, Valerie, joined by Patient Ambassador, Tab, treated with AMVUTTRA, and Abdul Bikak, a healthcare professional.
Register
Patient Educational Event
Tucson, Arizona
May 07, 2026 |
5:30 PM-7:00 PM MT
Hear from an Alnylam Patient Education Liaison, Rita, joined by Patient Ambassador, Art, treated with AMVUTTRA, and Paula McDermott, a healthcare professional.
Register
Patient Educational Event
Virtual Program
May 11, 2026 |
6:00 PM-8:30 PM ET
Hear from an Alnylam Patient Education Liaison, Sue, joined by Patient Ambassador, Scott, treated with AMVUTTRA, and Chris Bell, a healthcare professional.
Register
Patient Educational Event
Roseville, California
May 12, 2026 |
6:00 PM-7:30 PM PT
Hear from an Alnylam Patient Education Liaison, Paul, joined by Patient Ambassador, Paul, treated with AMVUTTRA, and Nancy Luo, a healthcare professional.
Register
Patient Educational Event
New York City, New York
May 13, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Christopher, joined by Patient Ambassador, Scott, treated with AMVUTTRA, and Brendan Carry, a healthcare professional..
Register
Patient Educational Event
Leola, Pennsylvania
May 13, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Sue, joined by Patient Ambassador, Marty, treated with AMVUTTRA.
Register
Patient Educational Event
Manchester, New Hampshire
May 14, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Kathleen, joined by Patient Ambassador, Marc, treated with AMVUTTRA, and Olakunle Akinboboye, a healthcare professional.
Register
Patient Educational Event
Los Angeles, California
May 19, 2026 |
6:30 PM-8:00 PM PT
Hear from an Alnylam Patient Education Liaison, Rita, joined by Patient Ambassador, Tim, treated with AMVUTTRA, and Richard Wright, a healthcare professional.
Register
Patient Educational Event
Oklahoma City, Oklahoma
May 21, 2026 |
6:00 PM-7:30 PM CT
Hear from an Alnylam Patient Education Liaison, Diane, joined by Patient Ambassador, Giselle, treated with AMVUTTRA, and Robert Long, a healthcare professional.
Register
Patient Educational Event
Tampa, Florida
May 21, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Teresa, joined by Patient Ambassador, Ed, treated with AMVUTTRA, and Penny, their spouse and caregiver, and Elaine Perkins, a healthcare professional.
Register
Patient Educational Event
Beechwood, Ohio
May 28, 2026 |
6:30 PM-8:00 PM ET
Hear from an Alnylam Patient Education Liaison, Shane, joined by Patient Ambassador, Marty, treated with AMVUTTRA, and Olakunle Akinboboye, a healthcare professional.
Register
Patient Educational Event
Virtual Program
June 09, 2026 |
7:00 PM-8:30 PM CT
Hear from an Alnylam Patient Education Liaison, Angela, joined by Patient Ambassador, John, treated with AMVUTTRA, and Richard Wright, a healthcare professional.
Register
Patient Educational Event
Bay Head, New Jersey
June 10, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Sue, joined by Patient Ambassador, Steve, treated with AMVUTTRA.
Register
Patient Educational Event
Seal Beach, California
June 10, 2026 |
6:00 PM-7:30 PM PT
Hear from an Alnylam Patient Education Liaison, Rita, joined by Patient Ambassador, Al, treated with AMVUTTRA, and Deborah, their spouse and caregiver, and Richard Wright, a healthcare professional.
Register
Patient Educational Event
Naples, Florida
June 11, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Teresa, joined by Patient Ambassador, Art, treated with AMVUTTRA, and Elsy Navas, a healthcare professional.
Register
Patient Educational Event
Pittsburgh, Pennsylvania
June 11, 2026 |
6:30 PM-8:00 PM ET
Hear from an Alnylam Patient Education Liaison, Shane, joined by Patient Ambassador, Marty, treated with AMVUTTRA, and Jennifer Keeley, a healthcare professional.
Register
Patient Educational Event
Cleveland, Ohio
June 12, 2026 |
6:30 PM-8:00 PM ET
Hear from an Alnylam Patient Education Liaison, Shane, and Olakunle Akinboboye, a healthcare professional.
Register
Patient Educational Event
Garden City, New York
June 17, 2026 |
6:00 PM-7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Christopher, joined by Patient Ambassador, Al, treated with AMVUTTRA, and Deborah, their spouse and caregiver, and Marc Goldschmidt, a healthcare professional.
RegisterImportant Safety Information
What are the most important things I should know about AMVUTTRA® (vutrisiran)?
AMVUTTRA can cause low vitamin A levels
Treatment with AMVUTTRA lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.
Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking AMVUTTRA, talk to your doctor. Your doctor may refer you to an eye specialist.
What are the common side effects of AMVUTTRA?
The most common side effects of AMVUTTRA were pain in the arms or legs, pain in the joints, shortness of breath, and low vitamin A levels.
These are not all the possible side effects of AMVUTTRA. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA). Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For additional information about AMVUTTRA, please see the full Prescribing Information.
Indications
What is AMVUTTRA?
AMVUTTRA is a prescription medicine that treats the:
- cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce heart-related death, hospital stays and urgent visits.
- polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Important Safety Information and Indications
Important Safety Information
What are the most important things I should know about AMVUTTRA® (vutrisiran)?
AMVUTTRA can cause low vitamin A levels
Treatment with AMVUTTRA lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.
Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking AMVUTTRA, talk to your doctor. Your doctor may refer you to an eye specialist.
What are the common side effects of AMVUTTRA?
The most common side effects of AMVUTTRA were pain in the arms or legs, pain in the joints, shortness of breath, and low vitamin A levels.
These are not all the possible side effects of AMVUTTRA. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA). Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For additional information about AMVUTTRA, please see the full Prescribing Information.
Indications
What is AMVUTTRA?
AMVUTTRA is a prescription medicine that treats the:
- cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce heart-related death, hospital stays and urgent visits.
- polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.